Decoding and overcoming T cell exhaustion: Epigenetic and transcriptional dynamics in CAR-T cells against solid

Taeyoung Ahn1, Eun-Ah Bae2, Hyungseok Seo1

  • 1Laboratory of Cell & Gene Therapy, Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.

Insights

T cell exhaustion impairs therapies like CAR-T. Researchers identified three T cell exhaustion subsets and key molecular drivers, offering new strategies for cancer treatment.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • T cell exhaustion is a state of T cell dysfunction observed in chronic infections and cancer.
  • It is characterized by impaired immune cell function and reduced proliferation.
  • T cell exhaustion limits the effectiveness of adoptive T cell therapies, including chimeric antigen receptor (CAR)-T cell therapy.

Purpose of the Study:

  • To elucidate the mechanisms underlying T cell exhaustion.
  • To categorize exhausted T cells into distinct subsets based on developmental and functional profiles.
  • To identify key molecular regulators involved in T cell exhaustion.

Main Methods:

  • Classification of exhausted T cells into three subsets: stem-like progenitor, intermediate, and terminal.
  • Analysis of transcriptional and epigenetic regulatory mechanisms.
  • Investigation of key transcription factors (TCF1, BACH2, TOX) and epigenetic regulators (TET2, DNMT3A).

Main Results:

  • Exhausted T cells comprise three distinct subsets with unique developmental and functional characteristics.
  • Transcriptional and epigenetic modulators synergistically regulate these T cell exhaustion subsets.
  • Specific transcription factors and epigenetic regulators are critical for maintaining exhaustion phenotypes.

Conclusions:

  • Understanding the hierarchical structure and molecular complexity of T cell exhaustion is crucial.
  • This knowledge can inform the development of improved T cell-based cancer therapies.
  • Targeting molecular drivers of T cell exhaustion may enhance therapeutic efficacy in oncology.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
716
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904